Cutaneous Manifestations of Reactions to Biologics |
| |
Authors: | Iris M Otani Amy S Levin Aleena Banerji |
| |
Institution: | 1.Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine,University of California San Francisco,San Francisco,USA;2.Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Harvard Medical School,Massachusetts General Hospital,Boston,USA |
| |
Abstract: | Purpose of ReviewThe goal of this paper is to review the major adverse cutaneous reactions that have been reported to the most commonly used biologics.Recent FindingsAnti-TNF agents and immune checkpoint inhibitors have significant, immune-mediated cutaneous manifestations that can necessitate discontinuation. Anti-TNF agents, IL-6 inhibitors, and IL-12/23 inhibitors can paradoxically cause psoriasis flares or unmask previously undiagnosed psoriasis. IL-17 inhibitors are unique in increasing risk for Candida infections. Benign injection site reactions, non-specific rash, cellulitis, and hypersensitivity reactions are relatively common adverse events.SummaryA wide variety of cutaneous reactions caused by biologics have been reported, ranging from benign injection site reactions to life-threatening cutaneous reactions necessitating discontinuation of the implicated biologic agent. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|